No Data
No Data
The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $17
B.Riley Financial Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $15
B. Riley Adjusts Price Target on ClearPoint Neuro to $15 From $14, Maintains Buy Rating
Express News | Clearpoint Neuro Inc : Stifel Raises Target Price to $17 From $10
ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...